Liraglutide

Hold

Tools

A GLP-1 receptor agonist medication used for diabetes and obesity treatment.

Why it's here

Placed in Hold: 1 article(s) of evidence from 1 source(s), led by research-stage coverage, with 0 in the last 30 days. Confidence 24%. Low accumulated evidence, so it defaults conservatively pending more signal.

Evidence (1)

5Hacker News·6/27/2026research
Ozempic May Affect Mood Through the Gut-Brain Axis
A reported study suggests GLP-1 drugs such as Ozempic and liraglutide may do more than support weight loss by also reducing depression-like behavior in mice. The effect appears to depend on gut microbes, especially Lactobacillus delbrueckii, which may produce endocannabinoids linked to stress reduction.